MATTER launches initiative to strengthen digital marketing capabilities of small healthcare businesses on Chicago’s West and South Sides

Selected healthcare organizations will participate in complimentary program to connect to digital-forward customers CHICAGO–(BUSINESS WIRE)–MATTER, the premier healthcare incubator and innovation hub, today launched a new program to strengthen small healthcare businesses in Chicago’s West Side and South Side communities by connecting them to digital-forward customers. Connecting with customers and competing for their attention is … [Read more…]

Schrödinger Reports Inducement Grants To Newly Appointed Chief Financial Officer

NEW YORK–(BUSINESS WIRE)–Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced the grant of inducement equity awards to the company’s newly appointed chief financial officer, Geoffrey Porges, MBBS. As previously announced, Dr. Porges joined the company on August 18, 2022. The grants were approved by … [Read more…]

Henry Schein Advances ESG Stewardship

Issues First Task Force on Climate-Related Financial Disclosures Report Discloses 2021 ESG Progress in First Corporate Social Responsibility Report Prepared in Accordance with Sustainability Accounting Standards Board and Global Reporting Initiative Standards Donates More Than $21.5 Million in Cash and Product in 2021 in Furtherance of Its Goal of Donating at Least $50 Million by … [Read more…]

Surge for Water Hosts Annual Gala in Chicago at Moonlight Studios

CHICAGO–(BUSINESS WIRE)–Surge for Water, a 501c3 nonprofit based in Chicago and Dubai, invests in communities with safe water, sanitation, hygiene, and menstrual health solutions, hosts its annual gala at Moonlight Studios, September 24, 2022, in Chicago. With a “Vintage Circus” theme, attendees will be awed by jugglers, stilt walkers, tarot card readers, and more. More … [Read more…]

MedAllies Selects Lyniate for Enhanced Identity Data Management Capabilities

Top connectivity services company will leverage Lyniate EMPI solution to strengthen the accuracy of the data it exchanges to better serve its clients and partners BOSTON–(BUSINESS WIRE)–Lyniate, a global leader in healthcare data interoperability, today announced MedAllies, a leading multimodality connectivity services company, has chosen Lyniate Enterprise Master Patient Index (EMPI) by NextGate to better … [Read more…]

Aurion Biotech Nominated for Prix Galien Startup Award

Prix Galien USA Awards Ceremony in New York City, October 27, 2022 SEATTLE & BOSTON & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has been nominated for the prestigious Prix Galien Startup Award. The Galien Foundation, the premier global institution dedicated … [Read more…]

Monkeypox Is an STD, No More Time to Waste, Says AHF

Two respected scientists and doctors make a strong case in a recent Medium article for monkeypox to be formally classified and considered a sexually transmitted infection (STI) AHF believes classifying the virus as an STI more accurately reflects transmission of the new clade or strain of the virus, which is primarily affecting gay men, and … [Read more…]

Paradigm Convergence Technologies Corporation says that Monkeypox Illustrates Need For Constant Infection Control

LITTLE RIVER, S.C.–(BUSINESS WIRE)–$PCTL #healthcare–PCT LTD (OTC Pink: PCTL): Since the initial outbreak of the COVID-19 virus in early 2020, healthcare systems around the world have faced numerous additional widespread infection threats. Whether these are new waves of COVID variants or the recent spread of monkeypox, they illustrate the need for hospitals and long-term care … [Read more…]

Dermaliq Therapeutics announces first patient dosed in Phase 1b/2 trial evaluating DLQ02 for treatment of plaque psoriasis

WILMINGTON, Del.–(BUSINESS WIRE)–Dermaliq Therapeutics, Inc. (Dermaliq), a private, clinical stage pharmaceutical company with a focus on dermatology, today announced first patient dosed in a Phase 1b/2a trial with DLQ02, a topical calcineurin inhibitor. The trial is designed to evaluate the safety, systemic absorption, pharmacodynamics, and clinical efficacy of DLQ02 in patients with plaque psoriasis. “DLQ02 … [Read more…]